Cargando…

Comparison of global extracellular volume (ECV) and late gadolinium enhancement (LGE) to predict the estimated 5 year risk of sudden cardiac death (SCD) in patients with hypertrophic cardiomyopathy (HCM)

Detalles Bibliográficos
Autores principales:	Avanesov, Maxim, Weinrich, Julius, Münch, Julia, Well, Lennart, Säring, Dennis, Müllerleile, Kai, Tahir, Enver, Patten, Monica, Adam, Gerhard, Lund, Gunnar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032276/ http://dx.doi.org/10.1186/1532-429X-18-S1-P127

Ejemplares similares

Size of myocardial fibrosis by LGE, pre- and post-contrast T1 and ECV in patients with hypertrophic cardiomyopathy referenced to normal appearing myocardium or healthy volunteers
por: Avanesov, Maxim, et al.
Publicado: (2015)

Extent of late gadolinium enhancement in patients with hypertrophic cardiomyopathy in correlation with serum MMP9 as an indicator of myocardial fibrosis
por: Avanesov, Maxim, et al.
Publicado: (2014)

Late gadolinium enhancement (LGE) on Cardiac MR is a powerful predictor of death and “hard” events in patients with hypertrophic cardiomyopathy (HCM)
por: Bhatti, Sabha, et al.
Publicado: (2012)

Late gadolinium enhancement as an independent predictor of atrial fibrillation in hypertrophic cardiomyopathy (HCM)
por: O'Hanlon, Rory, et al.
Publicado: (2009)

Late gadolinium enhancement score (LGE-Score) for prediction of extensive late gadolinium enhancement in hypertrophic cardiomyopathy
por: Chan, Raymond H, et al.
Publicado: (2015)

Comparison of classical Fabry and its p.D313Y and p.A143T variants by cardiac T1 mapping, LGE and feature tracking myocardial strain
por: Avanesov, Maxim, et al.
Publicado: (2023)

Left Ventricular Fibrosis Assessment by Native T1, ECV, and LGE in Pulmonary Hypertension Patients
por: Cerne, John W., et al.
Publicado: (2022)

Regional adenosine-induced hypoperfusion without hyperenhancement on LGE-MRI in young HCM patients: comparison to subjects at risk of HCM and healthy volunteers
por: Jablonowski, Robert, et al.
Publicado: (2015)

Not all LGE is the same. Scar contrast volume of distribution is lower in HCM than in infarction
por: Treibel, Thomas A, et al.
Publicado: (2012)

Ability of extracellular volume imaging to serially measure infarct size compared to LGE within six months after acute myocardial infarction
por: Sinn, Martin R, et al.
Publicado: (2015)

Association of Asymmetric Dimethylarginine and Diastolic Dysfunction in Patients with Hypertrophic Cardiomyopathy
por: Cordts, Kathrin, et al.
Publicado: (2019)

Patients with hypertrophic cardiomyopathy (HCM) and HCM gene carriers have attenuated myocardial oxygenation response to vasodilator stress - a potential mechanism for sudden cardiac death
por: Dass, Sairia, et al.
Publicado: (2012)

External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2021)

Radiomics Analysis Derived From LGE-MRI Predict Sudden Cardiac Death in Participants With Hypertrophic Cardiomyopathy
por: Wang, Jie, et al.
Publicado: (2021)

Effects on blood pressure, cardiac mass and function after renal denervation in patients with resistant hypertension
por: Tahir, Enver, et al.
Publicado: (2016)

Septal Ablation in Obstructive Hypertrophic Cardiomyopathy (oHCM)
por: Almeida, Dirceu Rodrigues
Publicado: (2019)

Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: proof of additional diagnostic value compared to conventional late gadolinium enhancement (LGE) imaging
por: Florian, Anca, et al.
Publicado: (2014)

Accuracy and saving of time using a new algorithm for quantitative measurement of infarct and edema size in patients with acute myocardial infarction
por: Lund, Gunnar, et al.
Publicado: (2014)

A systematic review for sudden cardiac death in hypertrophic cardiomyopathy patients with myocardial fibrosis: a CMR LGE study
por: Silva, Nackle J, et al.
Publicado: (2012)

Vigorous Exercise in Patients with Hypertrophic Cardiomyopathy: Results of the Prospective, Observational, Multinational, “Lifestyle and Exercise in HCM” (LIVE-HCM) Study
por: Lampert, Rachel, et al.
Publicado: (2023)

Molecular Diagnosis of Hypertrophic Cardiomyopathy (HCM): In the Heart of Cardiac Disease
por: Melas, Marilena, et al.
Publicado: (2022)

Development of cardiac remodeling in patients with acute myocardial infarction studied by cardiac MRI (CMR)
por: Sinn, Martin R, et al.
Publicado: (2015)

ShMOLLI and 5(4R) 3 MOLLI T1 mapping in HCM detect similar ECV despite a difference in absolute T1 measurements
por: Gonzalez, Jorge A, et al.
Publicado: (2015)

Split dose versus single bolus gadolinium administration in ecv calculation at 3 tesla cmr
por: McDiarmid, Adam K, et al.
Publicado: (2015)

Prediction of thrombo‐embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk‐CVA)
por: Guttmann, Oliver P., et al.
Publicado: (2015)

Feline Hypertrophic Cardiomyopathy: A Spontaneous Large Animal Model of Human HCM
por: Freeman, Lisa M., et al.
Publicado: (2017)

Quality of life and societal costs in hypertrophic cardiomyopathy: protocol of the AFFECT-HCM study
por: Schoonvelde, Stephan A. C., et al.
Publicado: (2023)

Adult Onset Hypertrophic Cardiomyopathy (HCM) Not Detected by Echocardiogram: A Case Presentation
por: Elsouri, Kawther N, et al.
Publicado: (2023)

CMR feature tracking strain patterns and their association with circulating cardiac biomarkers in patients with hypertrophic cardiomyopathy
por: Cavus, Ersin, et al.
Publicado: (2021)

Performance of automated ECV maps versus conventionally calculated ECV
por: Rosmini, Stefania, et al.
Publicado: (2015)

Histopathology in HCM
por: Tejado, Beatriz San Millán, et al.
Publicado: (2018)

Modified wideband 3D late gadolinium enhancement (LGE) MRI for patients with implantable cardiac devices
por: Rashid, Shams, et al.
Publicado: (2015)

Late gadolinium enhancement (LGE) progresses with right ventricle volume in children after repair of tetralogy of fallot()
por: Ylitalo, Pekka, et al.
Publicado: (2014)

Dark-Blood Late Gadolinium Enhancement MRI Is Noninferior to Bright-Blood LGE in Non-Ischemic Cardiomyopathies
por: Brendel, Jan M., et al.
Publicado: (2023)

Global extracellular volume (ECVglobal) in HCM - the "next generation" test for risk in hypertrophic cardiomyopathy?
por: Sado, Daniel, et al.
Publicado: (2013)

Venous dysfunction in obstructive hypertrophic cardiomyopathies: Results from the “HCM-Vein” pilot study
por: Réant, Patricia, et al.
Publicado: (2023)

Sudden Cardiac Death Risk over Time in HCM Patients with Implantable Cardioverter-Defibrillator
por: Klopotowski, Mariusz, et al.
Publicado: (2022)

3.0T motion-corrected single-shot phase sensitive inversion recovery (PSIR) late gadolinium enhancement (LGE) in free-breathing patients compared with conventional segmented breath-held LGE
por: Lin, Lu, et al.
Publicado: (2015)

Improved 3D late gadolinium enhancement (LGE) imaging with dynamic-TI in patients with persistent atrial fibrillation
por: Keegan, Jennifer, et al.
Publicado: (2014)

Cardiac MRI utilizing late gadolinium enhancement (LGE) and T1 mapping in the detection of radiation induced heart disease
por: Ricco, Anthony, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7kshvk3ofo2mq1r0ndk9jqfkrb